冠状病毒疾病威胁管理的战略和行动计划

1 ContentsAt A Glance: Executive summary............................................................................................3Foreword...............................................................................................................................5Acknowledgements...............................................................................................................6Acronyms..............................................................................................................................7Introduction...........................................................................................................................8Context..............................................................................................................................8Purpose of this document...................................................................................................9Target audience..................................................................................................................9Scope..............................................................................................................................10Document structure.........................................................................................................10Strategic objectives..............................................................................................................12Call-out box: Leveraging lessons from COVID-19...........................................................13Operationalizingthe strategic objectives across core public health capabilities.....................15C1.Collaborative surveillance....................................................................................15C2.Community protection..........................................................................................17C3.Safe and scalable Care.........................................................................................19C4.Access to and delivery of medical Countermeasures.............................................20C5.Coordination........................................................................................................22Cross-cutting enablers.....................................................................................................24Call-out box: Equity considerations...............................................................................25Implementation approach....................................................................................................26World Health Organization................................................................................................26WHO’s mechanisms of action.......................................................................................27Coordinating WHO’s response......................................................................................27Technical and implementation partners............................................................................27Civil society organizations................................................................................................28Research institutions & academia.....................................................................................28Private sector...................................................................................................................28Communities...................................................................................................................28Interlinkages with other strategic documents........................................................................29Monitoring and evaluation....................................................................................................31Approach.........................................................................................................................31Data collection, management, and validation....................................................................31Key indicators..................................................................................................................32 2 ContextOver five years since the detection of the first COVID-19 cases, SARS-CoV-2 continues to circulate globally,causing acute illness, hospitalization, and death, alongside prolonged negative impacts on individuals,health systems, and economies, including post-COVID-19 condition (PCC or Long COVID). While globalpopulation-level immunity has increased significantly through both infection and vaccination, the viruscontinues to evolve, challenging control efforts and underscoring the need for long-term, sustainabledisease management. Confirming earlier warnings from MERS-CoV and SARS-CoV-1, SARS-CoV-2 hasdemonstrated the pandemic potential of coronaviruses, which remain one of the most consequentialinfectious disease threats of our time.Purpose of the strategic and operational planThis plan sets out WHO’s